ArticleEuropean journal of medical research2025

Impact of KIT mutation on efficacy of venetoclax and hypomethylating agents in newly diagnosed acute myeloid leukemia.

Wenxiu Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.